Elaine Unemori

Who is Elaine Unemori?

Dr. Unemori

has studied relaxin for over 15 years, starting at Genentech, Inc., where

she performed key experiments that demonstrated relaxin’s ability to

initiate remodeling of connective tissue in non-reproductive tissues.

As

one of the founding members of Connetics Corporation and their Senior

Director of Preclinical Research, Elaine led a multidisciplinary group

that explored new indications for relaxin. The work of this group led

to several clinical trials in which relaxin demonstrated clinically

meaningful pharmacological effects. Elaine also led the clinical

development team investigating the use of relaxin in infertility/IVF.

In positions

at Genentech, Stanford University’s Department of Dermatology, and

Connetics Corporation, Elaine has established collaborations with leading

investigators in many scientific areas, including women’s health,

cardiovascular medicine, wound healing, rheumatology, and dermatology.

Elaine has numerous publications in peer-reviewed journals and is the

holder of five US patents, all relating to relaxin.

Elaine received her Ph.D. from the

University

of

California

at Berkeley

and did her postdoctoral training in connective tissue biology with Dr. Zena

Werb at the

University

of

California

at San Francisco.